Congratulations to our Winners

The most promising and innovative Biovision Investor Biotech Startup is



Geoffroy DE RIBAINS

Step Pharma

Development of a new class of oral immunomodulators for the treatment of autoimmune diseases and cancer

 


The most promising and innovative Biovision Investor Medtech Startup is



Clark TEDFORD

LumiThera

LumiThera is a developing a non-invasive treatment to prevent vision loss in patients with degenerative eye disease

 


The Biovision Investor Selection committee Special award goes to



Jean-Yves QUENTEL

Mensia Technologies

Mensia Koala is a home-based, non-invasive medical device for the care of ADHD.

 




The most promising and innovative Catalyzer project is



Carla SNOECK

GlycoDelete

GlycoDelete is a novel glyco-engineering platform technology for the design and development of next-generation biopharmaceuticals.

 


The most promising and innovative Catalyzer Startup is



Bruno Berge

Laclarée

Laclarée develops electronic eyeglasses for people having difficulties with progressive lenses.

 


The Catalyzer Selection committee Special awards go to



Christophe GAUDIN

Op2Lysis

We develop the first treatment of hemorrhagic stroke, which affects 1.5 M patients every year

 


BIOVISION Essentials


Relive The sessions on Youtube

All the sessions (not workshops) were filmed and are now available on our Youtube Channel. Do not hesitate to comment to continue the debate.

Read More...


Congratulaitons to our Winners

The awards of the Biovision Catalyzer and Investor were given to ... STEP PHARMA, LUMITHERA, MENSIA TECHNOLOGIES, GLYCODELETE, LACLARÉE, OP2LYSIS

Read More...


Photos of the 12th edition

Our Photographer, Walid Boo Pics, took pictures of the attendees, speakers, experts and of the forum in general. You can view them on our Facebook page.

See the Pictures

Biovision's eyes

Each week Florence Gaudry-Perkins and Robert Sebbag will give you insights on life sciences, share articles, give their point of views, and help you understand the stakes of life sciences in the twenty first century.

Check out the Biovision's eyes


Our Partners